← Back to Clinical Trials
Recruiting NCT06737627

NCT06737627 Development and Validation of the Observatory Battery of Common Eye Disorders for Adults With Intellectual Disability

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06737627
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Intellectual Disability
Study Type OBSERVATIONAL
Enrollment 1,400 participants
Start Date 2024-04-09
Primary Completion 2027-01-29

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
no intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,400 participants in total. It began in 2024-04-09 with a primary completion date of 2027-01-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: Around 15% of the global population has some form of disability. Rights to obtain proper health care is an emphasis in the United Nationals Convention on the Right of People with Disability. Due to the importance of improving vision health for people with disabilities, studies on how to identify vision problems becomes extremely important in policy formulation for all countries. Among all types of disabilities, people with intellectual disability (ID) are among the ones where vision problems are the hardest to detect. Currently, no caregiver assessable scales are available, as a result, adults with ID are at high risk of delayed diagnose for common ocular conditions. Objectives: This is a one-year project. The objective of this study is two folds: 1. To develop an item bank of ocular conditions of adults with ID; 2. To develop a scale for caregivers to detect ocular conditions for adults with ID, and to validate the reliability, construct validity and responsiveness of the scale.

Eligibility Criteria

Inclusion Criteria: 1. Age 20 and above 2. Primary caregivers for at least one adult with ID (have disability identification or (and) certification). Exclusion Criteria: 1. Unable to communicate in Mandarin or Taiwanese.(Primarycaregivers) 2. Unable to cooperate with eye examination.(ID)

Contact & Investigator

Central Contact

Chiun-Ho Hou, Ph.D

✉ chiunhohou@gmail.com

📞 +88623123456

Frequently Asked Questions

Who can join the NCT06737627 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Intellectual Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06737627 currently recruiting?

Yes, NCT06737627 is actively recruiting participants. Contact the research team at chiunhohou@gmail.com for enrollment information.

Where is the NCT06737627 trial being conducted?

This trial is being conducted at New Taipei City, Taiwan, Taipei, Taiwan.

Who is sponsoring the NCT06737627 clinical trial?

NCT06737627 is sponsored by National Taiwan University Hospital. The trial plans to enroll 1,400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology